Emotional stress in police officers has been recognized as a modifiable risk factor for cardiovascular disease (CVD). The impact of stress on health, however, is determined by characteristics of the stress stimulus. For example, distinct responses may be induced by acute vs. chronic aversive stimuli. A systematic review of literature has so far not addressed the problem. Methods Studies published in English between January and December 2016 reported by PubMed, Isi Web of Science, CINAHL and PsychInfo were retrieved according to the PRISMA statement.
Background Cardiovascular diseases (CVDs) are still today a leading cause of disability and mortality. Each year nearly one fourth of all deaths due to CVD could be prevented through changes in life habits and management of risk factors. Diet and physical activity are central pillars of cardiovascular prevention. The aim of our research was to evaluate the impact of a multiple lifestyle intervention on the control of CVD modifiable risk factors with particular focus on the role of physical activity (PA) in both primary and secondary prevention. Methods A systematic review and a meta-analysis of randomized controlled trials (RCTs) was performed searching Pubmed, Web of Science and Cochrane Library until April 16th 2016. RCTs were selected if they investigated the impact of multiple lifestyle interventions on CVD risk factors in cardiovascular primary and secondary prevention. Changes in modifiable risk factors level from baseline were evaluated and data were combined through a random effects model. 
Key messages:
In the framework of multiple lifestyle intervention in cardiovascular disease prevention, a supervised PA intervention seems to impact more than PA advices only. In cardiovascular disease prevention a supervised PA intervention shows to have a considerable impact on blood pressure, anthropometric measures and blood lipids concentration. 
Light-moderate alcohol consumption and risk of atrial fibrillation

Methods
We used national hospital database to identify stroke patients discharged from hospitals between 2009 and 2014. We analyzed trends in SU admission and early (7 days) case fatality adjusting for age sex and comorbidy using logistic and Poisson regression. Results Hospital stroke admissions rose from 93 728 in 2009 to 109 456 in 2014. The proportion of patients admitted in SU nearly doubled during the period (from 23 to 44%). This was mainly attributable to more admissions of patients residing in medium and small towns. The mean age of ''SU patients'' remained below that of others but increased significantly faster over the study period (+2.5 years compared to + 1; p < 10-3). After accounting for age, stroke type and comorbidity, women remained less likely to be admitted to SU (OR for year 2014= 0.89 95%CI: 0.87;0.92). Crude 7 days case fatality decreased from 9.3% in 2009 to 8.1% in 2014 (annual trend= -2.37% 95%CI:-1.88;-2.85). Most of this trend was attributable to the increasing proportion of patients admitted in SU for whom early case fatality was more than halved (adjusted rate ratio: 0.44; 95% CI: 0.43-0.45). Conclusions Although in 2014 less than half of stroke patients in France were admitted to SU, deployment of the latter has improved access to older patients and to those residing outside major urban areas. More work is required to explain the persisting gender gap in SU admission and to measure how much the reduction in early case fatality translates into longer term benefits to patients.
Introduction
This study aimed to analyse changes in mean systolic blood pressure (SBP) and total cholesterol in relation to noncommunicable disease (NCD) policies in the WHO European countries between 2000 and 2014 for men and women. Methods Mean SBP and cholesterol levels for adults aged 25+ years were used from the estimates of Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group. The 2010 WHO Global NCD Country Capacity Survey (CCS) data were used to generate the NCD Policy Score (NCDPS). Absolute change in mean SBP and cholesterol levels between 2000 and 2014 was used to dichotomize countries into low and high performance using changes (2 mmHg in men and 3 mmHg women) as cut-off for SBP and 0.2mmol/L as cut off for change in cholesterol. Mann Whitney-U test was used to compare NCDPS between the groups. Logistic regression was used to analyse the association between NCDPS and change in SBP and cholesterol. R2 values indicated the variability explained in change in SBP and cholesterol by the NCDPS. Results Overall, mean SBP decreased in the WHO European Region, except for increases observed in 9 countries for men and 3 countries for women. Mean NCDPS scores did not differ between men in low and high performance countries (73.3 vs 84.1, p = 0.06). In women, the NCDPS were negatively associated with changes in SBP such that countries with higher NCDPS scores experienced higher SBP decreases (67.9 vs 85.5, p = 0.001). In logistic regression, NCDPS explained 13% and 33% of the variability in mean SBP change in men and women respectively. Mean total cholesterol levels decreased between 2000 and 2014 in all WHO European countries, except for Serbia. Change in cholesterol levels was not significantly associated with NCDPS in univariate or multivariate analyses. Conclusions There is a general decrease in mean SBP and cholesterol levels in WHO European countries between 2000 and 2014. NCD policy score explained more variability in SBP change in women.
Key messages:
There is a general decrease in mean SBP and cholesterol levels in WHO European countries between 2000 and 2014. A simple NCD control policy score developed from the WHO Global NCD CCS was not associated with the decrease in cholesterol.
